<?xml version="1.0"?>
<notificationOfRemoval>

    <schemaVersion>X0203</schemaVersion>

    <exchange>
        <cik>0001143313</cik>
        <entityName>NYSE Alternext US LLC</entityName>
    </exchange>

    <issuer>
        <cik>0001133416</cik>
        <entityName>PRO PHARMACEUTICALS INC</entityName>
        <fileNumber>001-31791</fileNumber>
        <address>
            <street1>189 Wells Street</street1>
            <street2>Suite 200</street2>
            <city>Newton</city>
            <stateOrCountryCode>MA</stateOrCountryCode>
            <stateOrCountry>MASSACHUSETTS</stateOrCountry>
            <zipCode>02459</zipCode>
        </address>
        <telephoneNumber>617-559-0033</telephoneNumber>
    </issuer>

    <descriptionClassSecurity>Common Stock, $0.001 Par Value</descriptionClassSecurity>

    <ruleProvision>17 CFR 240.12d2-2(b)</ruleProvision>

    <signatureData>
        <signatureName>Janice O'Neill</signatureName>
        <signatureTitle>Senior Vice President - Corporate Compliance</signatureTitle>
        <signatureDate>2009-03-04</signatureDate>
    </signatureData>
</notificationOfRemoval>
